文献速递前列腺癌

前列腺癌主动监测的国家趋势:基于医保理赔算法的验证

National Trends in Active Surveillance for Prostate Cancer: Validation of Medicare Claims-based Algorithms.
PubMed 文献 · Urology · 2018-07-07

研究利用密歇根医保数据与MUSIC注册库链接,验证8种基于理赔算法的主动监测识别性能,并将3种算法应用于全国20%医保样本描述趋势。算法敏感度23.5%-88.2%,特异度93.5%-99.1%;2007-2014年全国主动监测使用增加,但确诊率下降,且不足25%主动监测患者接受确认性活检。

要点

  • 基于理赔的算法识别主动监测敏感度和特异度变异大,需谨慎选择。
  • 2007-2014年全国前列腺癌确诊率下降,主动监测使用增加或稳定。
  • 主动监测患者中接受确认性活检的比例不足25%。

核心结论

  • 基于理赔的算法可用于识别主动监测,但性能差异大。
  • 全国范围内主动监测使用增加,但确诊率下降且确认性活检率低。

研究设计与样本

  • 回顾性队列研究,链接2012-2014年密歇根医保数据与MUSIC注册库,验证8种理赔算法。
  • 将3种算法应用于全国20%医保样本描述趋势。

主要发现

  • 8种算法敏感度23.5%-88.2%,特异度93.5%-99.1%。
  • 2007-2014年全国主动监测使用增加,前列腺癌诊断率下降。
  • 主动监测患者中接受确认性活检的比例不足25%。

临床怎么用

  • 临床中可参考验证后的理赔算法识别主动监测人群,但需注意敏感度差异。
  • 应关注主动监测患者确认性活检的低依从性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To better describe the real-world use of active surveillance. Active surveillance is a preferred management option for low-risk prostate cancer, yet its use outside of high-volume institutions is poorly understood. We created multiple claims-based algorithms, validated them using a robust clinical registry, and applied them to Medicare claims to describe national utilization. MATERIALS AND METHODS: We identified men with prostate cancer from 2012-2014 in a 100% sample of Michigan Medicare data and linked them with the Michigan Urologic Surgery Improvement Collaborative (MUSIC) registry. Using MUSIC treatment assignment as the standard, we determined the performance of 8 claims-based algorithms to identify men on active surveillance. We selected 3 algorithms (the most sensitive, the most specific, and a balanced algorithm incorporating age and comorbidity) and applied them to a 20% national Medicare sample to describe national trends. RESULTS: We identified 1186 men with incident prostate cancer and completely linked data. Eight algorithms were tested with sensitivity ranging from 23.5% to 88.2% and specificity ranging from 93.5% to 99.1%. We found that the use of surveillance for men with incident prostate cancer increased from 2007 to 2014, nationally. However, among all men in the population, there was a large decrease in the rate of prostate cancer diagnosis and an increased or stable rate in the use of active surveillance, depending on the algorithm used. Less than 25% of men on active surveillance underwent a confirmatory prostate biopsy. CONCLUSION: We describe the performance of claims-based algorithms to identify active surveillance.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Modi PK, Kaufman SR, Qi J, et al. National Trends in Active Surveillance for Prostate Cancer: Validation of Medicare Claims-based Algorithms. Urology. 2018. PMID: 29990573. doi:10.1016/j.urology.2018.06.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。